Solutions

INTELLECTUAL PROPERTY WATCH by Catherine Saez, Oct, 12, 2015

(Scroll down for Ministers' Statement.)

The health ministers of the Group of Seven (G7) most developed countries have issued a declaration on antimicrobial resistance and Ebola. The governments said they would explore innovative economic incentives to promote research and development of new antibiotics, such as a global antibiotic research fund and a market entry reward mechanism.

The G7 (Canada, France, Germany, Italy, Japan, United Kingdom, and United States) met from 8-9 October in Berlin and agreed to the Berlin Declaration [pdf] on Antimicrobial Resistance – Global Union for Antibiotics Research and Development (GUARD), aimed at supporting developing countries to develop national antimicrobial resistance action plans.

The G7 health ministers also issued a commitment on lessons learned from Ebola, and supported the 2005 World Health Organization International Health Regulations (IHR), insisting on the need to comply with them.

submitted by George Hurlburt

agenda.weforum.org - by Sania Nishtar - October 7, 2015

The recent, devastating Ebola crisis reminded the world of a hard truth:  Pandemics are not just a threat to human health, they are a threat to societies and economies. That there will be another pandemic is not a question of “if,” but a question of “when.”  A catastrophe on the scale of the 1918 flu epidemic could conceivably wipe out all development gains of the last century.  We recognize this, but, still we are unprepared.

(READ COMPLETE ARTICLE)

globalgoals.org - September 24, 2015

“Home" - Directed by Mark Grimmer, 59 Productions and produced by Richard Curtis in association with Global Citizen. Home is a reminder that the space we inhabit extends beyond our house, neighbourhood, country and even continent - and it’s up to us to take care of it.

http://www.globalgoals.org/

CLICK HERE - WHO - Developing Global Norms for Sharing Data and Results during Public Health Emergencies

blogs.bmj.com - by Trish Groves / The BMJ - September 8, 2015

The whole debate on sharing clinical study data has focused on transparency, reproducibility, and completing the evidence base for treatments. Yet public health emergencies such as the Ebola and MERS outbreaks provide a vitally important reason for sharing study data, usually before publication or even before submission to a journal, and ideally in a public repository.

(READ COMPLETE ARTICLE)

CLICK HERE - Wikipedia - Ingelfinger rule